EUVIMEDEUVIMED entdecken
Crossref

The Latest Topic of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) as Bofanglutide (GZR102)

International Journal of Endocrinology and Diabetes · 07.09.2026 · 9 (3) · 1-3

DOI: 10.36266/ijed/212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Endocrinology and Diabetes, online erschienen am 07.09.2026. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). The Latest Topic of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) as Bofanglutide (GZR102). International Journal of Endocrinology and Diabetes, 9(3), 1-3. https://doi.org/10.36266/ijed/212

Vancouver

The Latest Topic of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) as Bofanglutide (GZR102). International Journal of Endocrinology and Diabetes. 2026;9(3):1-3. doi:10.36266/ijed/212

BibTeX
@article{euvimed2026,
  title = {The Latest Topic of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) as Bofanglutide (GZR102)},
  journal = {International Journal of Endocrinology and Diabetes},
  year = {2026},
  volume = {9},
  number = {3},
  pages = {1--3},
  doi = {10.36266/ijed/212}
}
Kostenlos starten →